-
2 months ago | 
eyetube.net | I. Paul Singh
Innovations in Glaucoma: Procedural Pharmaceuticals I. Paul Singh, MD; and Steven R. Sarkisian Jr, MD Show Description + Steven R. Sarkisian Jr., MD, joins I. Paul Singh, MD, on Innovation Journal Club to discuss the impact of procedural pharmaceuticals on glaucoma management. Along with a review of a recent study on the topic, the two discuss how the advent of procedural pharmaceuticals enables a more proactive approach.
-
2 months ago | 
healio.com | I. Paul Singh |Anthony DeFino |Christine Klimanskis
Read more ORLANDO — In this Healio Video Perspective from Telling It Like It Is, I. Paul Singh, MD, shares how Dextenza can decrease the topical drop burden of steroids and improve efficiency of ophthalmic surgery. According to Singh, Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) reduces the amount of time ophthalmologists spend on patient education and follow-up, as well as time spent in discussions with insurance companies and pharmacies.
-
Mar 1, 2025 | 
eyetube.net | I. Paul Singh |Carl D. Regillo
Innovations in AMD Therapy: Second-Generation Anti-VEGFs I. Paul Singh, MD; and Carl D. Regillo, MD Show Description + In this episode of Innovation Journal Club, Carl Regillo, MD, and I. Paul Singh, MD, discuss outcomes from phase 3 studies of faricimab-svoa (Vabysmo, Genentech) and aflibercept 8 mg (Eyelea HD, Regeneron) in neovascular AMD. According to Dr. Regillo, the data suggests that these agents achieve greater durability and a better drying effect than first-generation anti-VEGF drugs.
-
Feb 18, 2025 | 
healio.com | I. Paul Singh |Anthony DeFino |Christine Klimanskis
ORLANDO — In this Healio Video Perspective from Telling It Like It Is, I. Paul Singh, MD, discusses utilizing the “robust” portfolio of technologies and devices to shift to an interventional glaucoma mindset. While topical therapies often lead to patient noncompliance, new technologies empower ophthalmologist to “take control back to our hands as providers,” according to Singh.
-
Feb 12, 2025 | 
healio.com | I. Paul Singh |Anthony DeFino |Christine Klimanskis
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD,discusses the AquaLumen, a subconjunctival bypass technology to lower IOP in patients with glaucoma. AquaLumen (PLU Ophthalmic) allows ophthalmologists to enter the anterior chamber through the sclera and create a tunnel for improved flow of fluid to the subconjunctival space.
-
Feb 10, 2025 | 
healio.com | I. Paul Singh |Anthony DeFino |Christine Klimanskis
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD,discusses the benefits of using AlloFlo to create a cyclodialysis cleft in patients with glaucoma. According to Singh, AlloFlo (Iantrek), a bio-interventional enhancement for uveoscleral outflow, has shown good safety and efficacy to reinforce the cyclodialysis opening with sclera.
-
Jan 31, 2025 | 
healio.com | I. Paul Singh |Anthony DeFino |Christine Klimanskis
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, explains excimer laser trabeculostomy for the treatment of glaucoma. Eight-year data showed durability with excimer laser trabeculostomy (Bausch + Lomb) and efficacy consistent with conventional pathway MIGS. “I think for those surgeons who are thinking about MIGS but still have not adopted MIGS ...
-
Jan 2, 2025 | 
eyetube.net | I. Paul Singh |Sahar Bedrood
Innovations in MIGS: The Impact of Reimbursement Changes I. Paul Singh, MD; and Sahar Bedrood, MD, PhD Show Description + How have changes in MIGS reimbursement impacted clinical practice? Sahar Bedrood, MD, PhD, and I. Paul Singh, MD, review a recent study that suggested physicians changed their approach to glaucoma management in the wake of changes to Medicare reimbursement. The two discuss how other proposed changes may alter the treatment landscape.
-
Dec 21, 2024 | 
healio.com | I. Paul Singh |Anthony DeFino
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. CHICAGO — In this Healio Video Perspective from the AAO meeting, I. Paul Singh, MD, discusses his experience with the Artevo 850 heads-up display and its positive impact on ergonomics during surgery.
-
Nov 18, 2024 | 
eyetube.net | I. Paul Singh
The Role of Supraciliary MIGS in the Glaucoma Treatment Paradigm I. Paul Singh, MD Show Description + I. Paul Singh, MD, describes where the MINIject (iStar Medical) supraciliary MIGS device fits into his glaucoma treatment paradigm. He explains the limitations of trabecular meshwork-based MIGS devices and shares his clinical experience with the MINIject, discussing the device’s safety and efficacy.
